The results of our study also suggest that the mechanism of glycemic fluctuations during sleep in patients with OSA involves catecholamine-mediated effects induced through acute hypoxemia and/or counter-regulatory hormone responses, rather than altered insulin sensitivity. This evidence concerns the gene INS and obstructive sleep apnea syndrome.